MercyOne Des Moines Medical Center   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Des Moines IA United States (1893)

Organization Overview

First Clinical Trial
2019
NCT04266288
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Jan Franko, MD | MercyOne Des Moines Medical Center

Active Ingredients

Drugs in Phase 4 Trials (2)

ketamine (ketalar) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (1)

serum-derived bovine immunoglobulin/protein isolate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Emergencies (Phase 4)

Mucositis (Phase 2)

Suicidal Ideation (Phase 4)

Suicide (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3